Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaughan Carr

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Australian and New Zealand Journal of Psychiatry|December 4, 2016
Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact PsychosisVera A Morgan, Anna Waterreus, Vaughan Carr, et al.
Schizophrenia Research|August 20, 2015
CX3CR1 is dysregulated in blood and brain from schizophrenia patientsAurélie Bergon, Raoul Belzeaux, Magali Comte, et al.
Schizophrenia Research|July 25, 2016
Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophreniaJonathan L Hess, Daniel S Tylee, Rahul Barve, et al.
Schizophrenia Research|August 9, 2019
Transcriptomic abnormalities in peripheral blood in bipolar disorder, and discrimination of the major psychosesJonathan L Hess, Daniel S Tylee, Rahul Barve, et al.
BMJ Open|September 3, 2021
Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trialTony Butler, Peter W Schofield, Lee Knight, et al.
Schizophrenia Bulletin|August 19, 2016
White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network HubsPaul Klauser, Simon T Baker, Vanessa L Cropley, et al.
Longitudinal and Life Course Studies : International Journal|June 26, 2025
A study protocol for community implementation of a new mental health monitoring system spanning early childhood to young adulthoodJoyce Cleary, Catherine Nolan, Martin Guhn, et al.
The American Journal of Psychiatry|March 28, 2020
The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA ConsortiumLaurena Holleran, Sinead Kelly, Clara Alloza, et al.
Nature Genetics|March 14, 2023
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populationsDongjing Liu, Dara Meyer, Brian Fennessy, et al.
Molecular Psychiatry|February 9, 2024
Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA studyFoivos Georgiadis, Sara Larivière, David Glahn, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Australian and New Zealand Journal of Psychiatry|December 4, 2016
Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact PsychosisVera A Morgan, Anna Waterreus, Vaughan Carr, et al.
Schizophrenia Research|August 20, 2015
CX3CR1 is dysregulated in blood and brain from schizophrenia patientsAurélie Bergon, Raoul Belzeaux, Magali Comte, et al.
Schizophrenia Research|July 25, 2016
Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophreniaJonathan L Hess, Daniel S Tylee, Rahul Barve, et al.
Schizophrenia Research|August 9, 2019
Transcriptomic abnormalities in peripheral blood in bipolar disorder, and discrimination of the major psychosesJonathan L Hess, Daniel S Tylee, Rahul Barve, et al.
BMJ Open|September 3, 2021
Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trialTony Butler, Peter W Schofield, Lee Knight, et al.
Schizophrenia Bulletin|August 19, 2016
White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network HubsPaul Klauser, Simon T Baker, Vanessa L Cropley, et al.
Longitudinal and Life Course Studies : International Journal|June 26, 2025
A study protocol for community implementation of a new mental health monitoring system spanning early childhood to young adulthoodJoyce Cleary, Catherine Nolan, Martin Guhn, et al.
The American Journal of Psychiatry|March 28, 2020
The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA ConsortiumLaurena Holleran, Sinead Kelly, Clara Alloza, et al.
Nature Genetics|March 14, 2023
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populationsDongjing Liu, Dara Meyer, Brian Fennessy, et al.
Molecular Psychiatry|February 9, 2024
Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA studyFoivos Georgiadis, Sara Larivière, David Glahn, et al.
Pageof 5